Bio4Dreams has sold its stake in Euleria Health to Hi.Tech, a company of the We-COM Group specializing in integrated digital solutions for healthcare. The transaction marks the beginning of a new phase of maturity for the Trentino-based startup active in digital rehabilitation.

Founded in 2020 by David Tacconi and Roberto Tomasi together with Bio4Dreams as founding partner, Euleria Health was born and grew within the incubator’s ecosystem, which supported its entrepreneurial development and market positioning.

The innovative Trentino startup and Benefit Corporation develops digital devices and platforms for rehabilitation in orthopedic, neurological, and sports medicine, making advanced care and telerehabilitation programs accessible and measurable in any setting. In 2023, Bio4Dreams also supported the company in launching its equity crowdfunding campaign on CrowdFundMe, aimed at backing its international expansion plans and the development of proprietary software suites.

We-COM is an IT company with a team of professionals and consultants specialized in developing digital solutions and providing advisory services for businesses and public administrations, with a strong focus on digital transformation. Within the group, Hi.Tech is the entity dedicated to integrated digital solutions for healthcare.

Through the transfer of shares to Hi.Tech, Bio4Dreams completes a journey that saw the startup evolve from an early-stage entrepreneurial initiative into a company ready to embark on a new phase of industrial growth, in which the technological expertise of the We-COM Group will further enhance the impact of Euleria Health’s digital rehabilitation solutions.

Bio4Dreams views this transaction as the natural conclusion of a shared growth path and the beginning of a new chapter for Euleria Health.

In the share transfer process, Bio4Dreams was assisted by the law firm Studio Legale Grande Stevens, with lawyers Paolo Grande, Emanuele Cufalo, and Daniele Cericola.

“Bio4Dreams, founding partner of Euleria Health during the challenging Covid period, has contributed over the years to the consolidation and growth of this startup. Its acquisition by a leading industrial player in ICT for healthcare is the result of the solid work carried out by the company in digital rehabilitation, both remotely and at home. We wish the entire Euleria team all the best for this next chapter and for the exciting developments that are yet to come.”

Elisabetta Borello, Co-Founder, VP Strategy & External Relations of Bio4Dreams

📗 Learn more about how Bio4Dreams supports the growth of startups in the Life Sciences sector.